This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H3N8 Neuraminidase (NA), N-His
Product Overview
BioVenic's Recombinant Influenza A H3N8 Neuraminidase (NA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 45.5 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Neuraminidase is a tetrameric surface glycoprotein of the H3N8 Influenza A virus, a subtype predominantly associated with equine and canine infections. Functioning as a sialidase, NA cleaves terminal sialic acid residues from host cell receptors and viral hemagglutinin. This enzymatic activity prevents the aggregation of progeny virions and facilitates their release from the host cell membrane during budding. As a critical factor in viral spread and host-range adaptation, H3N8 NA is a major target for neuraminidase inhibitors and veterinary vaccine development.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.